Follow the Getinge AB stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Getinge AB has logged 10 reports. Market capitalisation: €64.3bn. The latest transaction was reported on 8 June 2026 (Purchase). Among the most active insiders: Johan Bygge. The full history is free.
10
Insider Decl.
n/a
Thresholds
€10m
10 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Getinge AB Buy (bullish), based on 10 analysts. Average price target: SEK 237.90.
31Σ signal
Buys €10mn/a Sells
Fundamental score
Ranked 12,305 of 29,053 companies
55.9
score / 100
Value
53
Quality
59
FCF yld4.0%
Earn yld3.4%
EV/EBITDA12.8x
ROE8.9%
Gross mgn48%
Net mgn6.5%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
1,000 shares@ SEK 180.50100.0% of flowAktieISINISIN SE0000202624FI:A001P603-2
10 of 10 declarations
About Getinge AB
Getinge AB is a Swedish company specializing in medical technology, providing solutions for intensive care, surgery, and rehabilitation. It is listed on the Stockholm Stock Exchange (XSTO).